The Journal of
Clinical Psychiatry

Volume 65 • 2004 • 4

Editorial

Sex and Psychiatry in the Next 5 Years

J Clin Psychiatry 2004;65(4):462-463

Katherine L. Wisner, MD, MS

Brainstorms

Brainstorms: Anticonvulsants as Anxiolytics, Part 2: Pregabalin and Gabapentin as α2Î´ Ligands at Voltage-Gated Calcium Channels

J Clin Psychiatry 2004;65(4):460-461

Stephen M. Stahl, MD, PhD

Original Research

Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs

J Clin Psychiatry 2004;65(4):464-470

Jambur Ananth, MD ; Sharat Parameswaran, BS ; Sarath Gunatilake, MD ; Karl Burgoyne, MD ; Taghrid Sidhom, MD

Original Research

Managing Atypical Antipsychotic-Associated Weight Gain: 12-Month Data on a Multimodal Weight Control Program

J Clin Psychiatry 2004;65(4):471-477

Matthew Menza, MD ; Betty Vreeland, APRN ; Shula Minsky, EdD ; Michael Gara, PhD ; Diane Rigassio Radler, MS, RD ; Marie Sakowitz, RD

Original Research

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Extended-Release Carbamazepine Capsules as Monotherapy for Bipolar Disorder Patients With Manic or Mixed Episodes

J Clin Psychiatry 2004;65(4):478-484

Richard H. Weisler, MD ; Amir H. Kalali, MD ; Terence A. Ketter, MD ; SPD417 Study Group

Original Research

Speed of Response and Remission in Major Depressive Disorder With Acute Electroconvulsive Therapy (ECT): A Consortium for Research in ECT (CORE) Report

J Clin Psychiatry 2004;65(4):485-491

Mustafa M. Husain, MD ; A. John Rush, MD ; Max Fink, MD ; Rebecca Knapp, PhD ; Georgios Petrides, MD ; Teresa Rummans, MD ; Melanie M. Biggs, PhD ; Kevin O'Connor, MD ; Keith Rasmussen, MD ; Marc Litle, MD ; Wenle Zhao, PhD ; Hilary J. Bernstein, MSW ; Glenn Smith, PhD ; Martina Mueller, PhD ; Shawn M. McClintock, MS ; Samuel H. Bailine, MD ; Charles H. Kellner, MD

Original Research

Hippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up

J Clin Psychiatry 2004;65(4):492-499

Thomas Frodl, MD ; Eva M. Meisenzahl, MD ; Thomas Zetzsche, MD ; Tom Höhne ; Sandra Banac, MD ; Constanze Schorr, MD ; Markus Jäger, MD ; Gerda Leinsinger, MD ; Ronald Bottlender, MD ; Maximilian Reiser, MD ; Hans-Jürgen Möller, MD

Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update

J Clin Psychiatry 2004;65(4):500-508

Alexander L. Miller, MD ; Catherine S. Hall, PharmD ; Robert W. Buchanan, MD ; Peter F. Buckley, MD ; John A. Chiles, MD ; Robert R. Conley, MD ; M. Lynn Crismon, PharmD ; Larry Ereshefsky, PharmD ; Susan M. Essock, PhD ; Molly Finnerty, MD ; Stephen R. Marder, MD ; Del D. Miller, MD, PharmD ; Joseph P. McEvoy, MD ; A. John Rush, MD ; Sy A. Saeed, MD ; Nina R. Schooler, PhD ; Steven P. Shon, MD ; Scott Stroup, MD ; Bernardo Tarin-Godoy, MD

Original Research

Suicide Attempts and Ideation in Patients With Bipolar I Disorder

J Clin Psychiatry 2004;65(4):509-514

Andrea Fagiolini, MD ; David J. Kupfer, MD ; Paola Rucci, D.Stat. ; John A. Scott, AM ; Danielle M. Novick, BA ; Ellen Frank, PhD

Original Research

Effect of Reboxetine on Major Depressive Disorder in Breast Cancer Patients: An Open-Label Study

J Clin Psychiatry 2004;65(4):515-520

Luigi Grassi, MD ; Bruno Biancosino, MD ; Luciana Marmai, MD ; Roberto Righi, MD

Original Research

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

J Clin Psychiatry 2004;65(4):521-530

Maurizio Fava, MD ; Craig H. Mallinckrodt, PhD ; Michael J. Detke, MD, PhD ; John G. Watkin, DPhil ; Madelaine M. Wohlreich, MD

Original Research

Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone

J Clin Psychiatry 2004;65(4):531-536

Henry A. Nasrallah, MD ; Inge Duchesne, MA ; Angelika Mehnert, PhD ; Carmela Janagap, MOS ; Mariëlle Eerdekens, MD

Original Research

Lack of Effect of Intravenous Immunoglobulins on Tics: A Double-Blind Placebo-Controlled Study

J Clin Psychiatry 2004;65(4):537-542

Pieter J. Hoekstra, MD ; Ruud B. Minderaa, MD, PhD ; Cees G. M. Kallenberg, MD, PhD

Original Research

Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in Major Depressive Disorder

J Clin Psychiatry 2004;65(4):543-546

George I. Papakostas, MD ; Timothy J. Petersen, PhD ; Dan V. Iosifescu, MD ; Paul Summergrad, MD ; Katherine G. Sklarsky, BA ; Jonathan E. Alpert, MD, PhD ; Andrew A. Nierenberg, MD ; Maurizio Fava, MD

Original Research

Hyperlipidemia in Persons Using Antipsychotic Medication: A General Population-Based Birth Cohort Study

J Clin Psychiatry 2004;65(4):547-550

Kaisa Saari, MD ; Hannu Koponen, MD, PhD ; Jaana Laitinen, PhD, MSc ; Jari Jokelainen, MSc ; Liisa Lauren, MD ; Matti Isohanni, MD, PhD ; Sari Lindeman, MD, PhD, MSc

Original Research

Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia

J Clin Psychiatry 2004;65(4):551-556

Jean-Pierre Lindenmayer, MD ; Pal Czobor, PhD ; Jan Volavka, MD, PhD ; Jeffrey A. Lieberman, MD ; Leslie Citrome, MD, MPH ; Brian Sheitman, MD ; Joseph P. McEvoy, MD ; Thomas B. Cooper, MA ; Miranda Chakos, MD

Original Research

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics

J Clin Psychiatry 2004;65(4):557-564

Natalie Alméras, PhD ; Jean-Pierre Després, PhD, FAHA ; Julie Villeneuve, B.Pharm. ; Marie-France Demers, MSc ; Marc-André Roy, MD ; Camille Cadrin, MD ; Jean-Pierre Mottard, MD ; Roch-Hugo Bouchard, MD

Original Research

Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine: A Placebo-Controlled Trial

J Clin Psychiatry 2004;65(4):565-568

Alexander Bystritsky, MD ; Deborah L. Ackerman, PhD ; Richard M. Rosen, MD ; Tanya Vapnik, RN, PhD ; Eda Gorbis, PhD ; Karron M. Maidment, RN ; Sanjaya Saxena, MD

Academic Highlights

International Consensus Group on Bipolar I Depression Treatment Guidelines

J Clin Psychiatry 2004;65(4):569-579

Joseph R. Calabrese, MD ; Siegfried Kasper, MD ; Gordon Johnson, MB, BS, FRANZCP, FRCPysch., DPM ; Osamu Tajima, MD, PhD ; Eduard Vieta, MD, PhD ; Lakshmi N. Yatham, MD ; Allan H. Young, MBChB, MPhil, PhD, MRCPsych

Worldview of Psychiatry

J Clin Psychiatry 2004;65(4):586-587

Justin J. Trevino, MD

Letter to the Editor

Lack of Association Between Plasma Apolipoprotein E and Suicide Attempts

J Clin Psychiatry 2004;65(4):580

Enrique Baca-García, MD ; Carmen Diaz-Sastre, MD ; Eloy Garcia-Resa, MD ; Antonio Ceverino, MD ; Antonio Ramirez, MD ; Jose de Leon, MD

Letter to the Editor

Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects

J Clin Psychiatry 2004;65(4):581-581

Gregory M. Asnis, MD ; Andrew H. Miller, MD ; Charles L. Raison, MD

Letter to the Editor

Reply to " Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects"

J Clin Psychiatry 2004;65(4):581-582

Michael R. Kraus, MD, PhD ; Arne SchÃ¤fer, MPsych

Letter to the Editor

Olanzapine May Cause Delirium in Geriatric Patients

J Clin Psychiatry 2004;65(4):583-583

Steven Samuels, MD ; Margaret Fang, MD

Letter to the Editor

A Case of Tardive Dystonia Successfully Managed With Quetiapine

J Clin Psychiatry 2004;65(4):583-584

Yukiya Sasak, MD ; Ichiro Kusumi, PhD ; Tsukasa Koyama, PhD

Letter to the Editor

A Rose by Any Other Name

J Clin Psychiatry 2004;65(4):584

Bruce Sutor, MD

Book Review

Quality Indicators; Defining and Measuring Quality in Psychiatric Care for Adults and Chiildren

J Clin Psychiatry 2004;65(4):585

Justin J. Trevino, MD

Volume 65 • 2004 • 4

Editorial

Sex and Psychiatry in the Next 5 Years

Brainstorms

Brainstorms: Anticonvulsants as Anxiolytics, Part 2: Pregabalin and Gabapentin as α2Î´ Ligands at Voltage-Gated Calcium Channels

Original Research

Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs

Managing Atypical Antipsychotic-Associated Weight Gain: 12-Month Data on a Multimodal Weight Control Program

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Extended-Release Carbamazepine Capsules as Monotherapy for Bipolar Disorder Patients With Manic or Mixed Episodes

Speed of Response and Remission in Major Depressive Disorder With Acute Electroconvulsive Therapy (ECT): A Consortium for Research in ECT (CORE) Report

Hippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update

Suicide Attempts and Ideation in Patients With Bipolar I Disorder

Effect of Reboxetine on Major Depressive Disorder in Breast Cancer Patients: An Open-Label Study

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone

Lack of Effect of Intravenous Immunoglobulins on Tics: A Double-Blind Placebo-Controlled Study

Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in Major Depressive Disorder

Hyperlipidemia in Persons Using Antipsychotic Medication: A General Population-Based Birth Cohort Study

Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics

Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine: A Placebo-Controlled Trial

Academic Highlights

International Consensus Group on Bipolar I Depression Treatment Guidelines

Worldview of Psychiatry

Worldview of Psychiatry

Letter to the Editor

Lack of Association Between Plasma Apolipoprotein E and Suicide Attempts

Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects

Reply to " Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects"

Olanzapine May Cause Delirium in Geriatric Patients

A Case of Tardive Dystonia Successfully Managed With Quetiapine

A Rose by Any Other Name

Book Review

Quality Indicators; Defining and Measuring Quality in Psychiatric Care for Adults and Chiildren

ELSEWHERE:

FOLLOW US:

Volume 65 • 2004 • 4

Editorial

Sex and Psychiatry in the Next 5 Years

Brainstorms

Brainstorms: Anticonvulsants as Anxiolytics, Part 2: Pregabalin and Gabapentin as α2Î´ Ligands at Voltage-Gated Calcium Channels

Original Research

Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs

Managing Atypical Antipsychotic-Associated Weight Gain: 12-Month Data on a Multimodal Weight Control Program

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Extended-Release Carbamazepine Capsules as Monotherapy for Bipolar Disorder Patients With Manic or Mixed Episodes

Speed of Response and Remission in Major Depressive Disorder With Acute Electroconvulsive Therapy (ECT): A Consortium for Research in ECT (CORE) Report

Hippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update

Suicide Attempts and Ideation in Patients With Bipolar I Disorder

Effect of Reboxetine on Major Depressive Disorder in Breast Cancer Patients: An Open-Label Study

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone

Lack of Effect of Intravenous Immunoglobulins on Tics: A Double-Blind Placebo-Controlled Study

Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in Major Depressive Disorder

Hyperlipidemia in Persons Using Antipsychotic Medication: A General Population-Based Birth Cohort Study

Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics

Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine: A Placebo-Controlled Trial

Academic Highlights

International Consensus Group on Bipolar I Depression Treatment Guidelines

Worldview of Psychiatry

Worldview of Psychiatry

Letter to the Editor

Lack of Association Between Plasma Apolipoprotein E and Suicide Attempts

Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects

Reply to " Ribavirin May Be an Important Factor in IFN-Induced Neuropsychiatric Effects"

Olanzapine May Cause Delirium in Geriatric Patients

A Case of Tardive Dystonia Successfully Managed With Quetiapine

A Rose by Any Other Name

Book Review

Quality Indicators; Defining and Measuring Quality in Psychiatric Care for Adults and Chiildren

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles